MedPath

The effect of Berberpim® syrup on Non-alcoholic fatty liver disease

Phase 3
Recruiting
Conditions
on-alcoholic fatty liver disease.
Fatty (change of) liver, not elsewhere classified
K76.0
Registration Number
IRCT20210814052178N1
Lead Sponsor
Kermanshah University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
46
Inclusion Criteria

Age over 18 years
Patients with grade I and II Non-alcoholic fatty liver disease according to the results of ultrasound, clinical interview, increase in liver enzymes and elimination of other causes this disease affects Non-alcoholic fatty liver

Exclusion Criteria

Patients with Hepatitis
Wilson's disease
People who drink alcohol
People with type I diabetes and type II diabetes who have been taking the drug for a year
Consumers of drugs that affect the level of liver enzymes such as Statins and Acetaminophen in high doses

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath